M6X Stock Overview
Operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Yield10 Bioscience, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.42 |
| 52 Week High | US$62.40 |
| 52 Week Low | US$3.84 |
| Beta | 1.69 |
| 1 Month Change | -10.58% |
| 3 Month Change | -15.50% |
| 1 Year Change | -92.80% |
| 3 Year Change | -97.27% |
| 5 Year Change | -99.38% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| M6X | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.6% | -0.5% |
| 1Y | -92.8% | -24.7% | 5.2% |
Return vs Industry: M6X underperformed the German Biotechs industry which returned -24.7% over the past year.
Return vs Market: M6X underperformed the German Market which returned 5.2% over the past year.
Price Volatility
| M6X volatility | |
|---|---|
| M6X Average Weekly Movement | 60.2% |
| Biotechs Industry Average Movement | 5.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: M6X's share price has been volatile over the past 3 months.
Volatility Over Time: M6X's weekly volatility has increased from 39% to 60% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 29 | Olly Peoples | www.yield10bio.com |
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017.
Yield10 Bioscience, Inc. Fundamentals Summary
| M6X fundamental statistics | |
|---|---|
| Market cap | €1.25m |
| Earnings (TTM) | -€12.12m |
| Revenue (TTM) | €276.51k |
4.5x
P/S Ratio-0.1x
P/E RatioIs M6X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| M6X income statement (TTM) | |
|---|---|
| Revenue | US$300.00k |
| Cost of Revenue | US$8.32m |
| Gross Profit | -US$8.02m |
| Other Expenses | US$5.12m |
| Earnings | -US$13.14m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -20.46 |
| Gross Margin | -2,674.33% |
| Net Profit Margin | -4,381.67% |
| Debt/Equity Ratio | -29.9% |
How did M6X perform over the long term?
See historical performance and comparison